Side Effects of iloperidone: A Synthesis of Findings from 14 Studies
- Home
- Side Effects of iloperidone
This analysis is based on research papers included in PubMed, but medical research is constantly evolving and may not fully reflect the latest findings. There may also be biases towards certain research areas.
This information is not medical advice and is not a substitute for diagnosis or treatment by a physician. If you have concerns about "Side Effects of iloperidone: A Synthesis of Findings from 14 Studies", please consult your doctor.
For NLM copyright information, please see Link to NLM Copyright Page
PubMed data is obtained via Hugging Face Datasets: Link to DatasetPlease check the disclaimer.
Main Research Findings
Iloperidone is a second-generation atypical antipsychotic that is commonly prescribed for the treatment of schizophrenia. 4
Iloperidone has a unique binding profile, demonstrating high affinity antagonism of both α1 adrenergic receptors and serotonin 2A receptors, which may contribute to its lower incidence of extrapyramidal side effects. 13
Iloperidone has been found to inhibit voltage-dependent K+ channels in vascular smooth muscle cells, specifically targeting the Kv1.5 subtype. 5
Iloperidone can prolong the QTc interval on an electrocardiogram, making it essential for physicians to monitor patients for heart rhythm issues. 14
Iloperidone can decrease the expression of CYP1A2 and CYP3A4 enzymes in human hepatocytes, potentially leading to drug-drug interactions when combined with other medications. 3
Reasons for Side Effects
Iloperidone's side effects are likely due to its interaction with various receptors and enzymes in the body, including dopamine, serotonin, adrenergic, and cytochrome P450 enzymes. 13 3
Common Side Effects
Weight Gain
Although iloperidone is considered to have a lower risk of weight gain compared to other atypical antipsychotics, it still can cause weight gain. 14 8
Metabolic Abnormalities
While iloperidone is associated with a lower risk of metabolic abnormalities compared to other atypical antipsychotics, it can still contribute to changes in lipid and glucose levels. 14 8
Extrapyramidal Symptoms (EPS)
Although iloperidone has a lower risk of EPS, it can still cause these symptoms, especially at higher doses. 14 8 2
Ejaculatory Dysfunction
Iloperidone can cause ejaculatory dysfunction, specifically retrograde ejaculation, due to its α1 adrenergic receptor antagonist properties. 11 6
QTc Prolongation
Iloperidone can prolong the QTc interval on the electrocardiogram, potentially leading to cardiac arrhythmias. 14
Drug Interactions
Iloperidone's inhibition of CYP1A2 and CYP3A4 enzymes can lead to drug interactions with other medications, affecting their metabolism and potentially leading to increased side effects or decreased efficacy. 3
Countermeasures for Side Effects
Weight Gain
Maintaining a healthy diet and regular exercise are crucial to minimize weight gain associated with iloperidone. 8
Metabolic Abnormalities
Regular monitoring of blood sugar, blood pressure, and cholesterol levels is essential to detect and manage metabolic abnormalities. 8
Extrapyramidal Symptoms (EPS)
If EPS occurs, consulting a doctor for treatment options such as antiparkinsonian drugs is important. 2
Ejaculatory Dysfunction
If ejaculatory dysfunction develops, discussing alternative medications or dosage adjustments with a doctor is recommended. 11 6
QTc Prolongation
Regular cardiac monitoring, such as electrocardiograms, is crucial for patients taking iloperidone to detect and manage QTc prolongation. 14
Drug Interactions
It's crucial to inform doctors about all medications being taken when starting iloperidone to prevent potential drug interactions. 3
Comparison Across Studies
Commonalities
Numerous studies have consistently shown that iloperidone has a lower risk of weight gain and metabolic abnormalities compared to other atypical antipsychotics. 14 8
Differences
Research on iloperidone's side effects can vary in results due to differences in study design and patient populations. For instance, the incidence of EPS can differ depending on the specific study and the dosage of iloperidone used. 8 2
Considerations for Real-Life Application
While iloperidone can be effective in treating schizophrenia, it's essential to be aware of its potential side effects. Open and honest communication with a doctor regarding all medications and medical history is critical to ensure safe and effective treatment. 14
Limitations of Current Research
Further research is needed to better understand iloperidone's long-term effects and its impact on individual patients. Additional studies are crucial to determine the precise mechanisms of its side effects and explore potential strategies for minimizing these risks. 8
Future Research Directions
Future research should focus on: 1) Long-term studies to assess the long-term effects of iloperidone and its impact on various patient populations; 2) Individualized medicine approaches to tailor treatment strategies based on patient-specific genetic and physiological factors; 3) Exploration of alternative medications or treatment approaches to minimize or prevent side effects while maintaining therapeutic efficacy. 8
Conclusion
Iloperidone is an effective treatment option for schizophrenia, but it's crucial to be aware of its potential side effects and engage in open communication with a doctor to manage these risks and ensure optimal care. 14
Benefit Keywords
Risk Keywords
Article Type
Author: MavissakalianMatig, PerelJames, GuoShenyang
Language : English
Author: SiafisSpyridon, WuHui, WangDongfang, BurschinskiAngelika, NomuraNobuyuki, TakeuchiHiroyoshi, Schneider-ThomaJohannes, DavisJohn M, LeuchtStefan
Language : English
Author: DanekPrzemysław J, WójcikowskiJacek, DanielWładysława A
Language : English
Author: NairAjay, SalemAmanie, AsamoahAnna-Lee, GosalRavipreet, GrossbergGeorge T
Language : English
Author: AnJin Ryeol, SeoMi Seon, JungHee Seok, KangMinji, HeoRyeon, BaeYoung Min, HanEun-Taek, YangSe-Ran, ParkWon Sun
Language : English
Author: RoughleyMatthew, LyallMarc
Language : English
Author: Kee ChoiYong, TaraziFrank I
Language : English
Author: SolmiMarco, MurruAndrea, PacchiarottiIsabella, UndurragaJuan, VeroneseNicola, FornaroMichele, StubbsBrendon, MonacoFrancesco, VietaEduard, SeemanMary V, CorrellChristoph U, CarvalhoAndré F
Language : English
Author: CitromeLeslie
Language : English
Author: OrsoliniL, TomasettiC, ValcheraA, VecchiottiR, MatarazzoI, VellanteF, IasevoliF, BuonaguroE F, FornaroM, FiengoA L C, MartinottiG, MazzaM, PernaG, CaranoA, De BartolomeisA, Di GiannantonioM, De BerardisD
Language : English
Language : English
Author: BrennanMark D
Language : English
Author: StahlStephen M
Language : English
Author: CitromeLeslie
Language : English
This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.